Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studies
Tuesday, April 21, 2009 - 06:56
in Mathematics & Economics
DENVER, Colorado and TUSTIN, Calif., April 21, 2009--Peregrine Pharmaceuticals, Inc.
Read the whole article on Science Blog
More from Science Blog
Related
- Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studiesTue, 21 Apr 2009, 7:57:22 EDT
- Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infectionsSun, 23 Nov 2008, 14:08:08 EST
- Bench to bedside: What's on the horizonSun, 19 Apr 2009, 15:43:23 EDT
- Developmental drug helps protect against radiation damageWed, 22 Apr 2009, 15:37:34 EDT
- Targeted agent shows promise in biliary cancer studyMon, 20 Apr 2009, 15:51:10 EDT